Rankings
▼
Calendar
ZVRA FY 2020 Earnings — Zevra Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ZVRA
Zevra Therapeutics, Inc.
$618M
FY 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$13M
+3.5% YoY
Gross Profit
$12M
90.2% margin
Operating Income
-$6M
-42.2% margin
Net Income
-$13M
-96.0% margin
EPS (Diluted)
$-3.21
Cash Flow
Operating Cash Flow
-$2M
Free Cash Flow
-$2M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$11M
Total Liabilities
$78M
Stockholders' Equity
-$66M
Cash & Equivalents
$4M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$13M
$13M
+3.5%
Gross Profit
$12M
$10M
+21.1%
Operating Income
-$6M
-$20M
+72.4%
Net Income
-$13M
-$25M
+48.0%
← Q4 2019
All Quarters
Q1 2020 →